Redifferentiation Therapy Using Alpha Lipoic Acid in Thyroid Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2013

Conditions
ThyroidCancer
Interventions
DRUG

alpha-lipoic acids

alpha-lipoic acid 600 mg/day or 1,200 mg/day 600 mg/day - Three tablets (200mg x 3), one time per day for 3 months 1,200 mg/day - Three tablets (200mg x 3), two times per day for 3 months

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER